Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1996 Oct;9(4):448–468. doi: 10.1128/cmr.9.4.448

Pediatric human immunodeficiency virus infection.

J B Domachowske 1
PMCID: PMC172904  PMID: 8894346

Abstract

In the past decade, an increase in pediatric human immunodeficiency virus (HIV) infection has had a substantial impact on childhood morbidity and mortality worldwide. The vertical transmission of HIV from mother to infant accounts for the vast majority of these cases. Identification of HIV-infected pregnant women needs to be impoved so that appropriate therapy can be initiated for both mothers and infants. While recent data demonstrate a dramatic decrease in HIV transmission from a subset of women treated with zidovudine during pregnancy, further efforts at reducing transmission are desperately needed. This review focuses on vertically transmitted HIV infection in children, its epidemiology, diagnostic criteria, natural history, and clinical manifestations including infectious and noninfectious complications. An overview of the complex medical management of these children ensues, including the use of antiretroviral therapy. Opportunistic infection prophylaxis is reviewed, along with the important role of other supportive therapies.

Full Text

The Full Text of this article is available as a PDF (359.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amadori A., De Rossi A., Chieco-Bianchi L., Giaquinto C., De Maria A., Ades A. E. Diagnosis of human immunodeficiency virus 1 infection in infants: in vitro production of virus-specific antibody in lymphocytes. Pediatr Infect Dis J. 1990 Jan;9(1):26–30. doi: 10.1097/00006454-199001000-00006. [DOI] [PubMed] [Google Scholar]
  2. Ammann A. J., Cowan M. J., Wara D. W., Weintrub P., Dritz S., Goldman H., Perkins H. A. Acquired immunodeficiency in an infant: possible transmission by means of blood products. Lancet. 1983 Apr 30;1(8331):956–958. doi: 10.1016/s0140-6736(83)92082-2. [DOI] [PubMed] [Google Scholar]
  3. Amorosa J. K., Miller R. W., Laraya-Cuasay L., Gaur S., Marone R., Frenkel L., Nosher J. L. Bronchiectasis in children with lymphocytic interstitial pneumonia and acquired immune deficiency syndrome. Plain film and CT observations. Pediatr Radiol. 1992;22(8):603–607. doi: 10.1007/BF02015366. [DOI] [PubMed] [Google Scholar]
  4. Anderson M. M., Morris R. E. HIV and adolescents. Pediatr Ann. 1993 Jul;22(7):436–446. doi: 10.3928/0090-4481-19930701-10. [DOI] [PubMed] [Google Scholar]
  5. Aricò M., Azzini M., Caselli D., Maccario R., Marseglia G., Michelone G. AIDS: outcome of children born to HTLV-III/LAV infected mothers. Report of 15 Italian cases. Helv Paediatr Acta. 1986 Mar;41(6):477–486. [PubMed] [Google Scholar]
  6. Auger I., Thomas P., De Gruttola V., Morse D., Moore D., Williams R., Truman B., Lawrence C. E. Incubation periods for paediatric AIDS patients. Nature. 1988 Dec 8;336(6199):575–577. doi: 10.1038/336575a0. [DOI] [PubMed] [Google Scholar]
  7. Bagasra O., Hauptman S. P., Lischner H. W., Sachs M., Pomerantz R. J. Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. N Engl J Med. 1992 May 21;326(21):1385–1391. doi: 10.1056/NEJM199205213262103. [DOI] [PubMed] [Google Scholar]
  8. Barbacci M., Repke J. T., Chaisson R. E. Routine prenatal screening for HIV infection. Lancet. 1991 Mar 23;337(8743):709–711. doi: 10.1016/0140-6736(91)90286-x. [DOI] [PubMed] [Google Scholar]
  9. Baskin D. H., Lax J. D., Barenberg D. Shigella bacteremia in patients with the acquired immune deficiency syndrome. Am J Gastroenterol. 1987 Apr;82(4):338–341. [PubMed] [Google Scholar]
  10. Bayard P. J., Berger T. G., Jacobson M. A. Drug hypersensitivity reactions and human immunodeficiency virus disease. J Acquir Immune Defic Syndr. 1992 Dec;5(12):1237–1257. [PubMed] [Google Scholar]
  11. Belman A. L., Diamond G., Dickson D., Horoupian D., Llena J., Lantos G., Rubinstein A. Pediatric acquired immunodeficiency syndrome. Neurologic syndromes. Am J Dis Child. 1988 Jan;142(1):29–35. doi: 10.1001/archpedi.1988.02150010039017. [DOI] [PubMed] [Google Scholar]
  12. Belman A. L., Ultmann M. H., Horoupian D., Novick B., Spiro A. J., Rubinstein A., Kurtzberg D., Cone-Wesson B. Neurological complications in infants and children with acquired immune deficiency syndrome. Ann Neurol. 1985 Nov;18(5):560–566. doi: 10.1002/ana.410180509. [DOI] [PubMed] [Google Scholar]
  13. Bennett J. V., Rogers M. F. Child survival and perinatal infections with human immunodeficiency virus. Am J Dis Child. 1991 Nov;145(11):1242–1247. doi: 10.1001/archpedi.1991.02160110034016. [DOI] [PubMed] [Google Scholar]
  14. Blanche S., Mayaux M. J., Rouzioux C., Teglas J. P., Firtion G., Monpoux F., Ciraru-Vigneron N., Meier F., Tricoire J., Courpotin C. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med. 1994 Feb 3;330(5):308–312. doi: 10.1056/NEJM199402033300502. [DOI] [PubMed] [Google Scholar]
  15. Blanche S., Rouzioux C., Moscato M. L., Veber F., Mayaux M. J., Jacomet C., Tricoire J., Deville A., Vial M., Firtion G. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group. N Engl J Med. 1989 Jun 22;320(25):1643–1648. doi: 10.1056/NEJM198906223202502. [DOI] [PubMed] [Google Scholar]
  16. Blanche S., Tardieu M., Duliege A., Rouzioux C., Le Deist F., Fukunaga K., Caniglia M., Jacomet C., Messiah A., Griscelli C. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms. Am J Dis Child. 1990 Nov;144(11):1210–1215. doi: 10.1001/archpedi.1990.02150350042021. [DOI] [PubMed] [Google Scholar]
  17. Blaser M. J., Hale T. L., Formal S. B. Recurrent shigellosis complicating human immunodeficiency virus infection: failure of pre-existing antibodies to confer protection. Am J Med. 1989 Jan;86(1):105–107. doi: 10.1016/0002-9343(89)90239-8. [DOI] [PubMed] [Google Scholar]
  18. Blecker U., Keymolen K., Lanciers S., Bahwere P., Souayah H., Levy J., Vandenplas Y. The prevalence of Helicobacter pylori positivity in human immunodeficiency virus-infected children. J Pediatr Gastroenterol Nutr. 1994 Nov;19(4):417–420. doi: 10.1097/00005176-199411000-00009. [DOI] [PubMed] [Google Scholar]
  19. Bremond-Gignac D., Aron-Rosa D., Rohrlich P., Deplus S., Faye A., Vilmer E. Rétinites à cytomégalovirus chez l'enfant atteint de SIDA de transmission materno-foetale. J Fr Ophtalmol. 1995;18(2):91–95. [PubMed] [Google Scholar]
  20. Bryson Y. J., Luzuriaga K., Sullivan J. L., Wara D. W. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med. 1992 Oct 22;327(17):1246–1247. doi: 10.1056/NEJM199210223271718. [DOI] [PubMed] [Google Scholar]
  21. Burgard M., Mayaux M. J., Blanche S., Ferroni A., Guihard-Moscato M. L., Allemon M. C., Ciraru-Vigneron N., Firtion G., Floch C., Guillot F. The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. The HIV Infection in Newborns French Collaborative Study Group. N Engl J Med. 1992 Oct 22;327(17):1192–1197. doi: 10.1056/NEJM199210223271702. [DOI] [PubMed] [Google Scholar]
  22. Butler K. M., De Smet M. D., Husson R. N., Mueller B., Manjunath K., Montrella K., Lovato G., Jarosinski P., Nussenblatt R. B., Pizzo P. A. Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency virus. J Pediatr. 1992 Mar;120(3):483–486. doi: 10.1016/s0022-3476(05)80926-6. [DOI] [PubMed] [Google Scholar]
  23. Butler K. M., Husson R. N., Balis F. M., Brouwers P., Eddy J., el-Amin D., Gress J., Hawkins M., Jarosinski P., Moss H. Dideoxyinosine in children with symptomatic human immunodeficiency virus infection. N Engl J Med. 1991 Jan 17;324(3):137–144. doi: 10.1056/NEJM199101173240301. [DOI] [PubMed] [Google Scholar]
  24. Butler K. M., Venzon D., Henry N., Husson R. N., Mueller B. U., Balis F. M., Jacobsen F., Lewis L. L., Pizzo P. A. Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine. Pediatrics. 1993 Apr;91(4):747–751. [PubMed] [Google Scholar]
  25. Bye M. R., Bernstein L., Shah K., Ellaurie M., Rubinstein A. Diagnostic bronchoalveolar lavage in children with AIDS. Pediatr Pulmonol. 1987 Nov-Dec;3(6):425–428. doi: 10.1002/ppul.1950030609. [DOI] [PubMed] [Google Scholar]
  26. Cassol S. A., Lapointe N., Salas T., Hankins C., Arella M., Fauvel M., Delage G., Boucher M., Samson J., Charest J. Diagnosis of vertical HIV-1 transmission using the polymerase chain reaction and dried blood spot specimens. J Acquir Immune Defic Syndr. 1992;5(2):113–119. [PubMed] [Google Scholar]
  27. Celum C. L., Chaisson R. E., Rutherford G. W., Barnhart J. L., Echenberg D. F. Incidence of salmonellosis in patients with AIDS. J Infect Dis. 1987 Dec;156(6):998–1002. doi: 10.1093/infdis/156.6.998. [DOI] [PubMed] [Google Scholar]
  28. Chandwani S., Borkowsky W., Krasinski K., Lawrence R., Welliver R. Respiratory syncytial virus infection in human immunodeficiency virus-infected children. J Pediatr. 1990 Aug;117(2 Pt 1):251–254. doi: 10.1016/s0022-3476(05)80539-6. [DOI] [PubMed] [Google Scholar]
  29. Chandwani S., Kaul A., Bebenroth D., Kim M., John D. D., Fidelia A., Hassel A., Borkowsky W., Krasinski K. Cytomegalovirus infection in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J. 1996 Apr;15(4):310–314. doi: 10.1097/00006454-199604000-00006. [DOI] [PubMed] [Google Scholar]
  30. Cheeseman S. H., Havlir D., McLaughlin M. M., Greenough T. C., Sullivan J. L., Hall D., Hattox S. E., Spector S. A., Stein D. S., Myers M. Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Feb 1;8(2):141–151. [PubMed] [Google Scholar]
  31. Chin J. Current and future dimensions of the HIV/AIDS pandemic in women and children. Lancet. 1990 Jul 28;336(8709):221–224. doi: 10.1016/0140-6736(90)91743-t. [DOI] [PubMed] [Google Scholar]
  32. Chintu C., Luo C., Baboo S., Khumalo-Ngwenya B., Mathewson J., DuPont H. L., Zumla A. Intestinal parasites in HIV-seropositive Zambian children with diarrhoea. J Trop Pediatr. 1995 Jun;41(3):149–152. doi: 10.1093/tropej/41.3.149. [DOI] [PubMed] [Google Scholar]
  33. Church J. A., Isaacs H., Saxon A., Keens T. G., Richards W. Lymphoid interstitial pneumonitis and hypogammaglobulinemia in children. Am Rev Respir Dis. 1981 Oct;124(4):491–496. doi: 10.1164/arrd.1981.124.4.491. [DOI] [PubMed] [Google Scholar]
  34. Clerici M., Roilides E., Butler K. M., DePalma L., Venzon D., Shearer G. M., Pizzo P. A. Changes in T-helper cell function in human immunodeficiency virus-infected children during didanosine therapy as a measure of antiretroviral activity. Blood. 1992 Nov 1;80(9):2196–2202. [PubMed] [Google Scholar]
  35. Clerici M., Shearer G. M. A TH1-->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993 Mar;14(3):107–111. doi: 10.1016/0167-5699(93)90208-3. [DOI] [PubMed] [Google Scholar]
  36. Cockerell C. J., Whitlow M. A., Webster G. F., Friedman-Kien A. E. Epithelioid angiomatosis: a distinct vascular disorder in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Lancet. 1987 Sep 19;2(8560):654–656. doi: 10.1016/s0140-6736(87)92442-1. [DOI] [PubMed] [Google Scholar]
  37. Cohen J. Pediatric AIDS vaccine trials set. Science. 1992 Dec 4;258(5088):1568–1570. doi: 10.1126/science.1455241. [DOI] [PubMed] [Google Scholar]
  38. Colebunders R., Mann J. M., Francis H., Bila K., Izaley L., Ilwaya M., Kakonde N., Quinn T. C., Curran J. W., Piot P. Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection. J Infect Dis. 1988 Feb;157(2):314–318. doi: 10.1093/infdis/157.2.314. [DOI] [PubMed] [Google Scholar]
  39. Connor E. M., McSherry G. Immune-based interventions in perinatal human immunodeficiency virus infection. Pediatr Infect Dis J. 1994 May;13(5):440–448. doi: 10.1097/00006454-199405000-00036. [DOI] [PubMed] [Google Scholar]
  40. Connor E. M., Sperling R. S., Gelber R., Kiselev P., Scott G., O'Sullivan M. J., VanDyke R., Bey M., Shearer W., Jacobson R. L. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994 Nov 3;331(18):1173–1180. doi: 10.1056/NEJM199411033311801. [DOI] [PubMed] [Google Scholar]
  41. Danner S. A., Carr A., Leonard J. M., Lehman L. M., Gudiol F., Gonzales J., Raventos A., Rubio R., Bouza E., Pintado V. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. N Engl J Med. 1995 Dec 7;333(23):1528–1533. doi: 10.1056/NEJM199512073332303. [DOI] [PubMed] [Google Scholar]
  42. De Rossi A., Ades A. E., Mammano F., Del Mistro A., Amadori A., Giaquinto C., Chieco-Bianchi L. Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection. AIDS. 1991 Jan;5(1):15–20. doi: 10.1097/00002030-199101000-00002. [DOI] [PubMed] [Google Scholar]
  43. DeHovitz J. A., Pape J. W., Boncy M., Johnson W. D., Jr Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1986 Jul 10;315(2):87–90. doi: 10.1056/NEJM198607103150203. [DOI] [PubMed] [Google Scholar]
  44. Dennehy P. J., Warman R., Flynn J. T., Scott G. B., Mastrucci M. T. Ocular manifestations in pediatric patients with acquired immunodeficiency syndrome. Arch Ophthalmol. 1989 Jul;107(7):978–982. doi: 10.1001/archopht.1989.01070020040025. [DOI] [PubMed] [Google Scholar]
  45. Denny T., Yogev R., Gelman R., Skuza C., Oleske J., Chadwick E., Cheng S. C., Connor E. Lymphocyte subsets in healthy children during the first 5 years of life. JAMA. 1992 Mar 18;267(11):1484–1488. [PubMed] [Google Scholar]
  46. Devash Y., Calvelli T. A., Wood D. G., Reagan K. J., Rubinstein A. Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. Proc Natl Acad Sci U S A. 1990 May;87(9):3445–3449. doi: 10.1073/pnas.87.9.3445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Dix R. D., Bredesen D. E., Erlich K. S., Mills J. Recovery of herpesviruses from cerebrospinal fluid of immunodeficient homosexual men. Ann Neurol. 1985 Nov;18(5):611–614. doi: 10.1002/ana.410180516. [DOI] [PubMed] [Google Scholar]
  48. Dix R. D., Waitzman D. M., Follansbee S., Pearson B. S., Mendelson T., Smith P., Davis R. L., Mills J. Herpes simplex virus type 2 encephalitis in two homosexual men with persistent lymphadenopathy. Ann Neurol. 1985 Feb;17(2):203–206. doi: 10.1002/ana.410170218. [DOI] [PubMed] [Google Scholar]
  49. Dondero T. J., Jr, Pappaioanou M., Curran J. W. Monitoring the levels and trends of HIV infection: the Public Health Service's HIV surveillance program. Public Health Rep. 1988 May-Jun;103(3):213–220. [PMC free article] [PubMed] [Google Scholar]
  50. Douglas G. C., King B. F. Maternal-fetal transmission of human immunodeficiency virus: a review of possible routes and cellular mechanisms of infection. Clin Infect Dis. 1992 Oct;15(4):678–691. doi: 10.1093/clind/15.4.678. [DOI] [PubMed] [Google Scholar]
  51. Douglas J. M., Critchlow C., Benedetti J., Mertz G. J., Connor J. D., Hintz M. A., Fahnlander A., Remington M., Winter C., Corey L. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med. 1984 Jun 14;310(24):1551–1556. doi: 10.1056/NEJM198406143102402. [DOI] [PubMed] [Google Scholar]
  52. Dunn D. T., Newell M. L., Ades A. E., Peckham C. S. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992 Sep 5;340(8819):585–588. doi: 10.1016/0140-6736(92)92115-v. [DOI] [PubMed] [Google Scholar]
  53. Dunn D. T., Nicoll A., Holland F. J., Davison C. F. How much paediatric HIV infection could be prevented by antenatal HIV testing? J Med Screen. 1995;2(1):35–40. doi: 10.1177/096914139500200110. [DOI] [PubMed] [Google Scholar]
  54. Dworkin B., Wormser G. P., Abdoo R. A., Cabello F., Aguero M. E., Sivak S. L. Persistence of multiply antibiotic-resistant Campylobacter jejuni in a patient with the acquired immune deficiency syndrome. Am J Med. 1986 May;80(5):965–970. doi: 10.1016/0002-9343(86)90646-7. [DOI] [PubMed] [Google Scholar]
  55. Ehrnst A., Lindgren S., Dictor M., Johansson B., Sönnerborg A., Czajkowski J., Sundin G., Bohlin A. B. HIV in pregnant women and their offspring: evidence for late transmission. Lancet. 1991 Jul 27;338(8761):203–207. doi: 10.1016/0140-6736(91)90347-r. [DOI] [PubMed] [Google Scholar]
  56. Ellaurie M., Burns E. R., Rubinstein A. Hematologic manifestations in pediatric HIV infection: severe anemia as a prognostic factor. Am J Pediatr Hematol Oncol. 1990 Winter;12(4):449–453. doi: 10.1097/00043426-199024000-00008. [DOI] [PubMed] [Google Scholar]
  57. Epstein L. G., Goudsmit J., Paul D. A., Morrison S. H., Connor E. M., Oleske J. M., Holland B. Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy. Ann Neurol. 1987 Apr;21(4):397–401. doi: 10.1002/ana.410210413. [DOI] [PubMed] [Google Scholar]
  58. Epstein L. G., Sharer L. R., Goudsmit J. Neurological and neuropathological features of human immunodeficiency virus infection in children. Ann Neurol. 1988;23 (Suppl):S19–S23. doi: 10.1002/ana.410230709. [DOI] [PubMed] [Google Scholar]
  59. Epstein L. G., Sharer L. R., Oleske J. M., Connor E. M., Goudsmit J., Bagdon L., Robert-Guroff M., Koenigsberger M. R. Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics. 1986 Oct;78(4):678–687. [PubMed] [Google Scholar]
  60. Erkeller-Yuksel F. M., Deneys V., Yuksel B., Hannet I., Hulstaert F., Hamilton C., Mackinnon H., Stokes L. T., Munhyeshuli V., Vanlangendonck F. Age-related changes in human blood lymphocyte subpopulations. J Pediatr. 1992 Feb;120(2 Pt 1):216–222. doi: 10.1016/s0022-3476(05)80430-5. [DOI] [PubMed] [Google Scholar]
  61. Erlich K. S., Mills J., Chatis P., Mertz G. J., Busch D. F., Follansbee S. E., Grant R. M., Crumpacker C. S. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1989 Feb 2;320(5):293–296. doi: 10.1056/NEJM198902023200506. [DOI] [PubMed] [Google Scholar]
  62. Etheridge S. P., Bolman R. M., 3rd, Braunlin E. A. Cytomegalovirus colitis in a pediatric heart transplant patient. Clin Transplant. 1994 Aug;8(4):409–412. [PubMed] [Google Scholar]
  63. Evatt B. L., Gomperts E. D., McDougal J. S., Ramsey R. B. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic. N Engl J Med. 1985 Feb 21;312(8):483–486. doi: 10.1056/NEJM198502213120805. [DOI] [PubMed] [Google Scholar]
  64. Farizo K. M., Buehler J. W., Chamberland M. E., Whyte B. M., Froelicher E. S., Hopkins S. G., Reed C. M., Mokotoff E. D., Cohn D. L., Troxler S. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA. 1992 Apr 1;267(13):1798–1805. [PubMed] [Google Scholar]
  65. Fast P. E., Walker M. C. Human trials of experimental AIDS vaccines. AIDS. 1993;7 (Suppl 1):S147–S159. [PubMed] [Google Scholar]
  66. Fauci A. S. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science. 1988 Feb 5;239(4840):617–622. doi: 10.1126/science.3277274. [DOI] [PubMed] [Google Scholar]
  67. Fiaccadori F., Elia G. F., Calzetti C., Degli Antoni A., Magnani G. Rhodococcus equi infection in HIV-positive patients: report of 5 cases and literature overview. Monaldi Arch Chest Dis. 1994 Dec;49(5):380–388. [PubMed] [Google Scholar]
  68. Fitzgibbon J. E., Gaur S., Frenkel L. D., Laraque F., Edlin B. R., Dubin D. T. Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation. N Engl J Med. 1993 Dec 16;329(25):1835–1841. doi: 10.1056/NEJM199312163292502. [DOI] [PubMed] [Google Scholar]
  69. Flomenberg P. R., Chen M., Munk G., Horwitz M. S. Molecular epidemiology of adenovirus type 35 infections in immunocompromised hosts. J Infect Dis. 1987 Jun;155(6):1127–1134. doi: 10.1093/infdis/155.6.1127. [DOI] [PubMed] [Google Scholar]
  70. Fontana I., Verrina E., Timitilli A., Arcuri V., Basile G., Losurdo G., Rabagliati A. M., Perfumo F., Giacchino R., Gusmano R. Cytomegalovirus infection in pediatric kidney transplantation. Transplant Proc. 1994 Feb;26(1):18–19. [PubMed] [Google Scholar]
  71. Fox J. D., Brink N. S., Zuckerman M. A., Neild P., Gazzard B. G., Tedder R. S., Miller R. F. Detection of herpesvirus DNA by nested polymerase chain reaction in cerebrospinal fluid of human immunodeficiency virus-infected persons with neurologic disease: a prospective evaluation. J Infect Dis. 1995 Oct;172(4):1087–1090. doi: 10.1093/infdis/172.4.1087. [DOI] [PubMed] [Google Scholar]
  72. Gabiano C., Tovo P. A., de Martino M., Galli L., Giaquinto C., Loy A., Schoeller M. C., Giovannini M., Ferranti G., Rancilio L. Mother-to-child transmission of human immunodeficiency virus type 1: risk of infection and correlates of transmission. Pediatrics. 1992 Sep;90(3):369–374. [PubMed] [Google Scholar]
  73. Gellert G. A., Durfee M. J., Berkowitz C. D., Higgins K. V., Tubiolo V. C. Situational and sociodemographic characteristics of children infected with human immunodeficiency virus from pediatric sexual abuse. Pediatrics. 1993 Jan;91(1):39–44. [PubMed] [Google Scholar]
  74. Goedert J. J., Mendez H., Drummond J. E., Robert-Guroff M., Minkoff H. L., Holman S., Stevens R., Rubinstein A., Blattner W. A., Willoughby A. Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120. Lancet. 1989 Dec 9;2(8676):1351–1354. doi: 10.1016/s0140-6736(89)91965-x. [DOI] [PubMed] [Google Scholar]
  75. Gutman L. T., St Claire K. K., Weedy C., Herman-Giddens M. E., Lane B. A., Niemeyer J. G., McKinney R. E., Jr Human immunodeficiency virus transmission by child sexual abuse. Am J Dis Child. 1991 Feb;145(2):137–141. doi: 10.1001/archpedi.1991.02160020027008. [DOI] [PubMed] [Google Scholar]
  76. Gwinn M., Pappaioanou M., George J. R., Hannon W. H., Wasser S. C., Redus M. A., Hoff R., Grady G. F., Willoughby A., Novello A. C. Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples. JAMA. 1991 Apr 3;265(13):1704–1708. [PubMed] [Google Scholar]
  77. Güngör T., Funk M., Linde R., Jacobi G., Horn M., Kreuz W. Cytomegalovirus myelitis in perinatally acquired HIV. Arch Dis Child. 1993 Mar;68(3):399–401. doi: 10.1136/adc.68.3.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Hall C. B., Powell K. R., MacDonald N. E., Gala C. L., Menegus M. E., Suffin S. C., Cohen H. J. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med. 1986 Jul 10;315(2):77–81. doi: 10.1056/NEJM198607103150201. [DOI] [PubMed] [Google Scholar]
  79. Halsey N. A., Markham R., Wahren B., Boulos R., Rossi P., Wigzell H. Lack of association between maternal antibodies to V3 loop peptides and maternal-infant HIV-1 transmission. J Acquir Immune Defic Syndr. 1992;5(2):153–157. [PubMed] [Google Scholar]
  80. Havlir D., Cheeseman S. H., McLaughlin M., Murphy R., Erice A., Spector S. A., Greenough T. C., Sullivan J. L., Hall D., Myers M. High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis. 1995 Mar;171(3):537–545. doi: 10.1093/infdis/171.3.537. [DOI] [PubMed] [Google Scholar]
  81. Hoyt L., Oleske J., Holland B., Connor E. Nontuberculous mycobacteria in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J. 1992 May;11(5):354–360. doi: 10.1097/00006454-199205000-00003. [DOI] [PubMed] [Google Scholar]
  82. Hu D. J., Heyward W. L., Byers R. H., Jr, Nkowane B. M., Oxtoby M. J., Holck S. E., Heymann D. L. HIV infection and breast-feeding: policy implications through a decision analysis model. AIDS. 1992 Dec;6(12):1505–1513. [PubMed] [Google Scholar]
  83. Hughes W. T., Kuhn S., Chaudhary S., Feldman S., Verzosa M., Aur R. J., Pratt C., George S. L. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med. 1977 Dec 29;297(26):1419–1426. doi: 10.1056/NEJM197712292972602. [DOI] [PubMed] [Google Scholar]
  84. Husson R. N., Chung Y., Mordenti J., Butler K. M., Chen S., Duliege A. M., Brouwers P., Jarosinski P., Mueller B. U., Ammann A. Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection. J Pediatr. 1992 Oct;121(4):627–633. doi: 10.1016/s0022-3476(05)81161-8. [DOI] [PubMed] [Google Scholar]
  85. Ingulli E., Tejani A., Fikrig S., Nicastri A., Chen C. K., Pomrantz A. Nephrotic syndrome associated with acquired immunodeficiency syndrome in children. J Pediatr. 1991 Nov;119(5):710–716. doi: 10.1016/s0022-3476(05)80284-7. [DOI] [PubMed] [Google Scholar]
  86. Intrumental perforation of the oesophagus. Lancet. 1984 Jun 9;1(8389):1279–1279. [PubMed] [Google Scholar]
  87. Jabs D. A., Enger C., Bartlett J. G. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 1989 Jan;107(1):75–80. doi: 10.1001/archopht.1989.01070010077031. [DOI] [PubMed] [Google Scholar]
  88. Jackson G. G., Perkins J. T., Rubenis M., Paul D. A., Knigge M., Despotes J. C., Spencer P. Passive immunoneutralization of human immunodeficiency virus in patients with advanced AIDS. Lancet. 1988 Sep 17;2(8612):647–652. doi: 10.1016/s0140-6736(88)90468-0. [DOI] [PubMed] [Google Scholar]
  89. Josephs S., Kim H. W., Brandt C. D., Parrott R. H. Parainfluenza 3 virus and other common respiratory pathogens in children with human immunodeficiency virus infection. Pediatr Infect Dis J. 1988 Mar;7(3):207–209. [PubMed] [Google Scholar]
  90. Joshi V. V., Gadol C., Connor E., Oleske J. M., Mendelson J., Marin-Garcia J. Dilated cardiomyopathy in children with acquired immunodeficiency syndrome: a pathologic study of five cases. Hum Pathol. 1988 Jan;19(1):69–73. doi: 10.1016/s0046-8177(88)80318-6. [DOI] [PubMed] [Google Scholar]
  91. Jura E., Chadwick E. G., Josephs S. H., Steinberg S. P., Yogev R., Gershon A. A., Krasinski K. M., Borkowsky W. Varicella-zoster virus infections in children infected with human immunodeficiency virus. Pediatr Infect Dis J. 1989 Sep;8(9):586–590. doi: 10.1097/00006454-198909000-00003. [DOI] [PubMed] [Google Scholar]
  92. Kahn E., Anderson V. M., Greco M. A., Magid M. Pancreatic disorders in pediatric acquired immune deficiency syndrome. Hum Pathol. 1995 Jul;26(7):765–770. doi: 10.1016/0046-8177(95)90225-2. [DOI] [PubMed] [Google Scholar]
  93. Karwowska S., Zolla-Pazner S. Passive immunization for the treatment and prevention of HIV infection. Biotechnol Ther. 1991;2(1-2):31–48. [PubMed] [Google Scholar]
  94. Katz M. H., Greenspan D., Westenhouse J., Hessol N. A., Buchbinder S. P., Lifson A. R., Shiboski S., Osmond D., Moss A., Samuel M. Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS. 1992 Jan;6(1):95–100. doi: 10.1097/00002030-199201000-00013. [DOI] [PubMed] [Google Scholar]
  95. Katz M. H., Mastrucci M. T., Leggott P. J., Westenhouse J., Greenspan J. S., Scott G. B. Prognostic significance of oral lesions in children with perinatally acquired human immunodeficiency virus infection. Am J Dis Child. 1993 Jan;147(1):45–48. doi: 10.1001/archpedi.1993.02160250047015. [DOI] [PubMed] [Google Scholar]
  96. Khouri Y. F., Mastrucci M. T., Hutto C., Mitchell C. D., Scott G. B. Mycobacterium tuberculosis in children with human immunodeficiency virus type 1 infection. Pediatr Infect Dis J. 1992 Nov;11(11):950–955. doi: 10.1097/00006454-199211110-00009. [DOI] [PubMed] [Google Scholar]
  97. Kilby J. M., Saag M. S. Is there a role for non-nucleoside reverse transcriptase inhibitors in the treatment of HIV infection? Infect Agents Dis. 1994 Dec;3(6):313–323. [PubMed] [Google Scholar]
  98. Kitchen V. S., Skinner C., Ariyoshi K., Lane E. A., Duncan I. B., Burckhardt J., Burger H. U., Bragman K., Pinching A. J., Weber J. N. Safety and activity of saquinavir in HIV infection. Lancet. 1995 Apr 15;345(8955):952–955. doi: 10.1016/s0140-6736(95)90699-1. [DOI] [PubMed] [Google Scholar]
  99. Kline M. W., Hollinger F. B., Rosenblatt H. M., Bohannon B., Kozinetz C. A., Shearer W. T. Sensitivity, specificity and predictive value of physical examination, culture and other laboratory studies in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection. Pediatr Infect Dis J. 1993 Jan;12(1):33–36. doi: 10.1097/00006454-199301000-00009. [DOI] [PubMed] [Google Scholar]
  100. Kornstein M. J., Pietra G. G., Hoxie J. A., Conley M. E. The pathology and treatment of interstitial pneumonitis in two infants with AIDS. Am Rev Respir Dis. 1986 Jun;133(6):1196–1198. doi: 10.1164/arrd.1986.133.6.1196. [DOI] [PubMed] [Google Scholar]
  101. Kotler D. P., Gaetz H. P., Lange M., Klein E. B., Holt P. R. Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med. 1984 Oct;101(4):421–428. doi: 10.7326/0003-4819-101-4-421. [DOI] [PubMed] [Google Scholar]
  102. Koup R. A., Brewster F., Grob P., Sullivan J. L. Nevirapine synergistically inhibits HIV-1 replication in combination with zidovudine, interferon or CD4 immunoadhesin. AIDS. 1993 Sep;7(9):1181–1184. doi: 10.1097/00002030-199309000-00005. [DOI] [PubMed] [Google Scholar]
  103. Kovacs A., Frederick T., Church J., Eller A., Oxtoby M., Mascola L. CD4 T-lymphocyte counts and Pneumocystis carinii pneumonia in pediatric HIV infection. JAMA. 1991 Apr 3;265(13):1698–1703. [PubMed] [Google Scholar]
  104. Krasinski K., Borkowsky W., Holzman R. S. Prognosis of human immunodeficiency virus infection in children and adolescents. Pediatr Infect Dis J. 1989 Apr;8(4):216–220. [PubMed] [Google Scholar]
  105. Krasinski K., Borkowsky W., Holzman R. S. Prognosis of human immunodeficiency virus infection in children and adolescents. Pediatr Infect Dis J. 1989 Apr;8(4):216–220. [PubMed] [Google Scholar]
  106. Landesman S., Weiblen B., Mendez H., Willoughby A., Goedert J. J., Rubinstein A., Minkoff H., Moroso G., Hoff R. Clinical utility of HIV-IgA immunoblot assay in the early diagnosis of perinatal HIV infection. JAMA. 1991 Dec 25;266(24):3443–3446. [PubMed] [Google Scholar]
  107. Leggiadro R. J., Barrett F. F., Hughes W. T. Extrapulmonary cryptococcosis in immunocompromised infants and children. Pediatr Infect Dis J. 1992 Jan;11(1):43–47. doi: 10.1097/00006454-199201000-00011. [DOI] [PubMed] [Google Scholar]
  108. Leibovitz E., Rigaud M., Chandwani S., Kaul A., Greco M. A., Pollack H., Lawrence R., Di John D., Hanna B., Krasinski K. Disseminated fungal infections in children infected with human immunodeficiency virus. Pediatr Infect Dis J. 1991 Dec;10(12):888–894. doi: 10.1097/00006454-199112000-00002. [DOI] [PubMed] [Google Scholar]
  109. Leibovitz E., Rigaud M., Pollack H., Lawrence R., Chandwani S., Krasinski K., Borkowsky W. Pneumocystis carinii pneumonia in infants infected with the human immunodeficiency virus with more than 450 CD4 T lymphocytes per cubic millimeter. N Engl J Med. 1990 Aug 23;323(8):531–533. doi: 10.1056/NEJM199008233230807. [DOI] [PubMed] [Google Scholar]
  110. Letvin N. L. Vaccines against human immunodeficiency virus--progress and prospects. N Engl J Med. 1993 Nov 4;329(19):1400–1405. doi: 10.1056/NEJM199311043291908. [DOI] [PubMed] [Google Scholar]
  111. Levin A. V., Zeichner S., Duker J. S., Starr S. E., Augsburger J. J., Kronwith S. Cytomegalovirus retinitis in an infant with acquired immunodeficiency syndrome. Pediatrics. 1989 Oct;84(4):683–687. [PubMed] [Google Scholar]
  112. Lewis L. L., Butler K. M., Husson R. N., Mueller B. U., Fowler C. L., Steinberg S. M., Pizzo P. A. Defining the population of human immunodeficiency virus-infected children at risk for Mycobacterium avium-intracellulare infection. J Pediatr. 1992 Nov;121(5 Pt 1):677–683. doi: 10.1016/s0022-3476(05)81892-x. [DOI] [PubMed] [Google Scholar]
  113. Lipshultz S. E., Chanock S., Sanders S. P., Colan S. D., Perez-Atayde A., McIntosh K. Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. Am J Cardiol. 1989 Jun 15;63(20):1489–1497. doi: 10.1016/0002-9149(89)90014-3. [DOI] [PubMed] [Google Scholar]
  114. Locatelli F., Percivalle E., Comoli P., Maccario R., Zecca M., Giorgiani G., De Stefano P., Gerna G. Human cytomegalovirus (HCMV) infection in paediatric patients given allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenaemia on patients' outcome. Br J Haematol. 1994 Sep;88(1):64–71. doi: 10.1111/j.1365-2141.1994.tb04978.x. [DOI] [PubMed] [Google Scholar]
  115. Luginbuhl L. M., Orav E. J., McIntosh K., Lipshultz S. E. Cardiac morbidity and related mortality in children with HIV infection. JAMA. 1993 Jun 9;269(22):2869–2875. [PubMed] [Google Scholar]
  116. MacPhail L. A., Greenspan D., Greenspan J. S. Recurrent aphthous ulcers in association with HIV infection. Diagnosis and treatment. Oral Surg Oral Med Oral Pathol. 1992 Mar;73(3):283–288. doi: 10.1016/0030-4220(92)90122-7. [DOI] [PubMed] [Google Scholar]
  117. Maloney M. J., Guill M. F., Wray B. B., Lobel S. A., Ebbeling W. Pediatric acquired immune deficiency syndrome with panhypogammaglobulinemia. J Pediatr. 1987 Feb;110(2):266–267. doi: 10.1016/s0022-3476(87)80170-1. [DOI] [PubMed] [Google Scholar]
  118. Marano B. J., Jr, Smith F., Bonanno C. A. Helicobacter pylori prevalence in acquired immunodeficiency syndrome. Am J Gastroenterol. 1993 May;88(5):687–690. [PubMed] [Google Scholar]
  119. Markowitz M., Saag M., Powderly W. G., Hurley A. M., Hsu A., Valdes J. M., Henry D., Sattler F., La Marca A., Leonard J. M. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med. 1995 Dec 7;333(23):1534–1539. doi: 10.1056/NEJM199512073332204. [DOI] [PubMed] [Google Scholar]
  120. Masur H. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex. N Engl J Med. 1993 Sep 16;329(12):898–904. doi: 10.1056/NEJM199309163291228. [DOI] [PubMed] [Google Scholar]
  121. McKinney R. E., Jr, Maha M. A., Connor E. M., Feinberg J., Scott G. B., Wulfsohn M., McIntosh K., Borkowsky W., Modlin J. F., Weintrub P. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group. N Engl J Med. 1991 Apr 11;324(15):1018–1025. doi: 10.1056/NEJM199104113241503. [DOI] [PubMed] [Google Scholar]
  122. McKinney R. E., Jr, Pizzo P. A., Scott G. B., Parks W. P., Maha M. A., Lehrman S. N., Riggs M., Eddy J., Lane B. A., Eppes S. C. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group. J Pediatr. 1990 Apr;116(4):640–647. doi: 10.1016/s0022-3476(05)81619-1. [DOI] [PubMed] [Google Scholar]
  123. McLoughlin L. C., Nord K. S., Joshi V. V., Oleske J. M., Connor E. M. Severe gastrointestinal involvement in children with the acquired immunodeficiency syndrome. J Pediatr Gastroenterol Nutr. 1987 Jul-Aug;6(4):517–524. doi: 10.1097/00005176-198707000-00004. [DOI] [PubMed] [Google Scholar]
  124. Merluzzi V. J., Hargrave K. D., Labadia M., Grozinger K., Skoog M., Wu J. C., Shih C. K., Eckner K., Hattox S., Adams J. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science. 1990 Dec 7;250(4986):1411–1413. doi: 10.1126/science.1701568. [DOI] [PubMed] [Google Scholar]
  125. Miles S. A., Balden E., Magpantay L., Wei L., Leiblein A., Hofheinz D., Toedter G., Stiehm E. R., Bryson Y. Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. Southern California Pediatric AIDS Consortium. N Engl J Med. 1993 Feb 4;328(5):297–302. doi: 10.1056/NEJM199302043280501. [DOI] [PubMed] [Google Scholar]
  126. Minkoff H., Nanda D., Menez R., Fikrig S. Pregnancies resulting in infants with acquired immunodeficiency syndrome or AIDS-related complex. Obstet Gynecol. 1987 Mar;69(3 Pt 1):285–287. [PubMed] [Google Scholar]
  127. Mintz M., Rapaport R., Oleske J. M., Connor E. M., Koenigsberger M. R., Denny T., Epstein L. G. Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. Am J Dis Child. 1989 Jul;143(7):771–774. doi: 10.1001/archpedi.1989.02150190021012. [DOI] [PubMed] [Google Scholar]
  128. Montalvo F. W., Casanova R., Clavell L. A. Treatment outcome in children with malignancies associated with human immunodeficiency virus infection. J Pediatr. 1990 May;116(5):735–738. doi: 10.1016/s0022-3476(05)82660-5. [DOI] [PubMed] [Google Scholar]
  129. Mueller B. U., Butler K. M., Husson R. N., Pizzo P. A. Pneumocystis carinii pneumonia despite prophylaxis in children with human immunodeficiency virus infection. J Pediatr. 1991 Dec;119(6):992–994. doi: 10.1016/s0022-3476(05)83065-3. [DOI] [PubMed] [Google Scholar]
  130. Neurologic signs in young children with human immunodeficiency virus infection. The European Collaborative Study. Pediatr Infect Dis J. 1990 Jun;9(6):402–406. doi: 10.1097/00006454-199006000-00007. [DOI] [PubMed] [Google Scholar]
  131. Nightingale S. D., Cameron D. W., Gordin F. M., Sullam P. M., Cohn D. L., Chaisson R. E., Eron L. J., Sparti P. D., Bihari B., Kaufman D. L. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med. 1993 Sep 16;329(12):828–833. doi: 10.1056/NEJM199309163291202. [DOI] [PubMed] [Google Scholar]
  132. O'Brien W. A., Grovit-Ferbas K., Namazi A., Ovcak-Derzic S., Wang H. J., Park J., Yeramian C., Mao S. H., Zack J. A. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood. 1995 Aug 1;86(3):1082–1089. [PubMed] [Google Scholar]
  133. Ogino M. T., Dankner W. M., Spector S. A. Development and significance of zidovudine resistance in children infected with human immunodeficiency virus. J Pediatr. 1993 Jul;123(1):1–8. doi: 10.1016/s0022-3476(05)81529-x. [DOI] [PubMed] [Google Scholar]
  134. Oxtoby M. J. Perinatally acquired human immunodeficiency virus infection. Pediatr Infect Dis J. 1990 Sep;9(9):609–619. [PubMed] [Google Scholar]
  135. Palasanthiran P., Ziegler J. B., Stewart G. J., Stuckey M., Armstrong J. A., Cooper D. A., Penny R., Gold J. Breast-feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant. J Infect Dis. 1993 Feb;167(2):441–444. doi: 10.1093/infdis/167.2.441. [DOI] [PubMed] [Google Scholar]
  136. Palomba E., Gay V., de Martino M., Fundaró C., Perugini L., Tovo P. A. Early diagnosis of human immunodeficiency virus infection in infants by detection of free and complexed p24 antigen. J Infect Dis. 1992 Feb;165(2):394–395. doi: 10.1093/infdis/165.2.394. [DOI] [PubMed] [Google Scholar]
  137. Parekh B. S., Shaffer N., Pau C. P., Abrams E., Thomas P., Pollack H., Bamji M., Kaul A., Schochetman G., Rogers M. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study. AIDS. 1991 Oct;5(10):1179–1184. doi: 10.1097/00002030-199110000-00004. [DOI] [PubMed] [Google Scholar]
  138. Patterson L. E., Butler K. M., Edwards M. S. Clinical herpes zoster shortly following primary varicella in two HIV-infected children. Clin Pediatr (Phila) 1989 Aug;28(8):354–354. [PubMed] [Google Scholar]
  139. Pattishall E. N., Noyes B. E., Orenstein D. M. Use of bronchoalveolar lavage in immunocompromised children with pneumonia. Pediatr Pulmonol. 1988;5(1):1–5. doi: 10.1002/ppul.1950050102. [DOI] [PubMed] [Google Scholar]
  140. Peckham C., Gibb D. Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med. 1995 Aug 3;333(5):298–302. doi: 10.1056/NEJM199508033330507. [DOI] [PubMed] [Google Scholar]
  141. Perkocha L. A., Rodgers G. M. Hematologic aspects of human immunodeficiency virus infection: laboratory and clinical considerations. Am J Hematol. 1988 Oct;29(2):94–105. doi: 10.1002/ajh.2830290207. [DOI] [PubMed] [Google Scholar]
  142. Perlman D. M., Ampel N. M., Schifman R. B., Cohn D. L., Patton C. M., Aguirre M. L., Wang W. L., Blaser M. J. Persistent Campylobacter jejuni infections in patients infected with the human immunodeficiency virus (HIV). Ann Intern Med. 1988 Apr;108(4):540–546. doi: 10.7326/0003-4819-108-4-540. [DOI] [PubMed] [Google Scholar]
  143. Petru A., Dunphy M. G., Azimi P., Janner D., Gallo D., Hanson C., Sohmer P., Stanley M. Reliability of polymerase chain reaction in the detection of human immunodeficiency virus infection in children. Pediatr Infect Dis J. 1992 Jan;11(1):30–33. doi: 10.1097/00006454-199201000-00008. [DOI] [PubMed] [Google Scholar]
  144. Pizzo P. A., Butler K., Balis F., Brouwers E., Hawkins M., Eddy J., Einloth M., Falloon J., Husson R., Jarosinski P. Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection. J Pediatr. 1990 Nov;117(5):799–808. doi: 10.1016/s0022-3476(05)83348-7. [DOI] [PubMed] [Google Scholar]
  145. Pizzo P. A., Eddy J., Falloon J., Balis F. M., Murphy R. F., Moss H., Wolters P., Brouwers P., Jarosinski P., Rubin M. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med. 1988 Oct 6;319(14):889–896. doi: 10.1056/NEJM198810063191401. [DOI] [PubMed] [Google Scholar]
  146. Quinn T. C., Kline R. L., Halsey N., Hutton N., Ruff A., Butz A., Boulos R., Modlin J. F. Early diagnosis of perinatal HIV infection by detection of viral-specific IgA antibodies. JAMA. 1991 Dec 25;266(24):3439–3442. [PubMed] [Google Scholar]
  147. Quinn T. C., Narain J. P., Zacarias F. R. AIDS in the Americas: a public health priority for the region. AIDS. 1990 Aug;4(8):709–724. [PubMed] [Google Scholar]
  148. Rakusan T. A., Parrott R. H., Sever J. L. Limitations in the laboratory diagnosis of vertically acquired HIV infection. J Acquir Immune Defic Syndr. 1991;4(2):116–121. [PubMed] [Google Scholar]
  149. Raszka W. V., Jr, Meyer G. A., Waecker N. J., Ascher D. P., Moriarty R. A., Fischer G. W., Robb M. L. Variability of serial absolute and percent CD4+ lymphocyte counts in healthy children born to human immunodeficiency virus 1-infected parents. Military Pediatric HIV Consortium. Pediatr Infect Dis J. 1994 Jan;13(1):70–72. [PubMed] [Google Scholar]
  150. Robertson C. A., Mok J. Y., Froebel K. S., Simmonds P., Burns S. M., Marsden H. S., Graham S. Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus. J Infect Dis. 1992 Oct;166(4):704–709. doi: 10.1093/infdis/166.4.704. [DOI] [PubMed] [Google Scholar]
  151. Rogers M. F., Jaffe H. W. Reducing the risk of maternal-infant transmission of HIV: a door is opened. N Engl J Med. 1994 Nov 3;331(18):1222–1223. doi: 10.1056/NEJM199411033311810. [DOI] [PubMed] [Google Scholar]
  152. Rogers M. F., Ou C. Y., Kilbourne B., Schochetman G. Advances and problems in the diagnosis of human immunodeficiency virus infection in infants. Pediatr Infect Dis J. 1991 Jul;10(7):523–531. doi: 10.1097/00006454-199107000-00009. [DOI] [PubMed] [Google Scholar]
  153. Rogers M. F., Ou C. Y., Rayfield M., Thomas P. A., Schoenbaum E. E., Abrams E., Krasinski K., Selwyn P. A., Moore J., Kaul A. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group. N Engl J Med. 1989 Jun 22;320(25):1649–1654. doi: 10.1056/NEJM198906223202503. [DOI] [PubMed] [Google Scholar]
  154. Rogers M. F., Thomas P. A., Starcher E. T., Noa M. C., Bush T. J., Jaffe H. W. Acquired immunodeficiency syndrome in children: report of the Centers for Disease Control National Surveillance, 1982 to 1985. Pediatrics. 1987 Jun;79(6):1008–1014. [PubMed] [Google Scholar]
  155. Roilides E., Black C., Reimer C., Rubin M., Venzon D., Pizzo P. A. Serum immunoglobulin G subclasses in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J. 1991 Feb;10(2):134–139. doi: 10.1097/00006454-199102000-00012. [DOI] [PubMed] [Google Scholar]
  156. Romero D. L., Busso M., Tan C. K., Reusser F., Palmer J. R., Poppe S. M., Aristoff P. A., Downey K. M., So A. G., Resnick L. Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8806–8810. doi: 10.1073/pnas.88.19.8806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Rossi G., Gorla R., Stellini R., Franceschini F., Bettinzioli M., Cadeo G., Sueri L., Cattaneo R., Marinone G. Prevalence, clinical, and laboratory features of thrombocytopenia among HIV-infected individuals. AIDS Res Hum Retroviruses. 1990 Feb;6(2):261–269. doi: 10.1089/aid.1990.6.261. [DOI] [PubMed] [Google Scholar]
  158. Rossi P., Moschese V., Wigzell H., Broliden P. A., Wahren B. Mother-to-infant transmission of HIV. Lancet. 1990 Feb 10;335(8685):359–360. doi: 10.1016/0140-6736(90)90651-k. [DOI] [PubMed] [Google Scholar]
  159. Rubinstein A., Bernstein L. J., Charytan M., Krieger B. Z., Ziprkowski M. Corticosteroid treatment for pulmonary lymphoid hyperplasia in children with the acquired immune deficiency syndrome. Pediatr Pulmonol. 1988 Jan-Feb;4(1):13–17. doi: 10.1002/ppul.1950040105. [DOI] [PubMed] [Google Scholar]
  160. Rubinstein A., Sicklick M., Gupta A., Bernstein L., Klein N., Rubinstein E., Spigland I., Fruchter L., Litman N., Lee H. Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA. 1983 May 6;249(17):2350–2356. [PubMed] [Google Scholar]
  161. Ruiz-Contreras J., Ramos J. T., Hernández-Sampelayo T., Gurbindo M. D., Garcia de José M., De Miguel M. J., Cilleruelo M. J., Mellado M. J. Sepsis in children with human immunodeficiency virus infection. The Madrid HIV Pediatric Infection Collaborative Study Group. Pediatr Infect Dis J. 1995 Jun;14(6):522–526. doi: 10.1097/00006454-199506000-00010. [DOI] [PubMed] [Google Scholar]
  162. Salmon D., Detruchis P., Leport C., Bouvet E., Karam D., Meyohas M. C., Coulaud J. P., Vildé J. L. Efficacy of zidovudine in preventing relapses of Salmonella bacteremia in AIDS. J Infect Dis. 1991 Feb;163(2):415–416. doi: 10.1093/infdis/163.2.415. [DOI] [PubMed] [Google Scholar]
  163. Salvador F., Blanco R., Colín A., Galán A., Gil-Gibernau J. J. Cytomegalovirus retinitis in pediatric acquired immunodeficiency syndrome: report of two cases. J Pediatr Ophthalmol Strabismus. 1993 May-Jun;30(3):159–162. doi: 10.3928/0191-3913-19930501-07. [DOI] [PubMed] [Google Scholar]
  164. Scadden D. T., Zon L. I., Groopman J. E. Pathophysiology and management of HIV-associated hematologic disorders. Blood. 1989 Oct;74(5):1455–1463. [PubMed] [Google Scholar]
  165. Scarlatti G., Albert J., Rossi P., Hodara V., Biraghi P., Muggiasca L., Fenyö E. M. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J Infect Dis. 1993 Jul;168(1):207–210. doi: 10.1093/infdis/168.1.207. [DOI] [PubMed] [Google Scholar]
  166. Schorr J. B., Berkowitz A., Cumming P. D., Katz A. J., Sandler S. G. Prevalence of HTLV-III antibody in American blood donors. N Engl J Med. 1985 Aug 8;313(6):384–385. doi: 10.1056/NEJM198508083130610. [DOI] [PubMed] [Google Scholar]
  167. Schwartz L. J., St Louis Y., Wu R., Wiznia A., Rubinstein A., Saenger P. Endocrine function in children with human immunodeficiency virus infection. Am J Dis Child. 1991 Mar;145(3):330–333. doi: 10.1001/archpedi.1991.02160030100030. [DOI] [PubMed] [Google Scholar]
  168. Scott G. B., Buck B. E., Leterman J. G., Bloom F. L., Parks W. P. Acquired immunodeficiency syndrome in infants. N Engl J Med. 1984 Jan 12;310(2):76–81. doi: 10.1056/NEJM198401123100202. [DOI] [PubMed] [Google Scholar]
  169. Scott G. B., Hutto C., Makuch R. W., Mastrucci M. T., O'Connor T., Mitchell C. D., Trapido E. J., Parks W. P. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med. 1989 Dec 28;321(26):1791–1796. doi: 10.1056/NEJM198912283212604. [DOI] [PubMed] [Google Scholar]
  170. Scott M. A., Graham B. S., Verrall R., Dixon R., Schaffner W., Tham K. T. Rhodococcus equi--an increasingly recognized opportunistic pathogen. Report of 12 cases and review of 65 cases in the literature. Am J Clin Pathol. 1995 May;103(5):649–655. doi: 10.1093/ajcp/103.5.649. [DOI] [PubMed] [Google Scholar]
  171. Seligmann M., Pinching A. J., Rosen F. S., Fahey J. L., Khaitov R. M., Klatzmann D., Koenig S., Luo N., Ngu J., Riethmüller G. Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update. Ann Intern Med. 1987 Aug;107(2):234–242. doi: 10.7326/0003-4819-107-2-234. [DOI] [PubMed] [Google Scholar]
  172. Selik R. M., Starcher E. T., Curran J. W. Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends. AIDS. 1987 Sep;1(3):175–182. [PubMed] [Google Scholar]
  173. Serwadda D., Mugerwa R. D., Sewankambo N. K., Lwegaba A., Carswell J. W., Kirya G. B., Bayley A. C., Downing R. G., Tedder R. S., Clayden S. A. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet. 1985 Oct 19;2(8460):849–852. doi: 10.1016/S0140-6736(85)90122-9. [DOI] [PubMed] [Google Scholar]
  174. Shannon K. M., Ammann A. J. Acquired immune deficiency syndrome in childhood. J Pediatr. 1985 Feb;106(2):332–342. doi: 10.1016/s0022-3476(85)80320-6. [DOI] [PubMed] [Google Scholar]
  175. Simonds R. J., Lindegren M. L., Thomas P., Hanson D., Caldwell B., Scott G., Rogers M. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group. N Engl J Med. 1995 Mar 23;332(12):786–790. doi: 10.1056/NEJM199503233321206. [DOI] [PubMed] [Google Scholar]
  176. Simonds R. J., Oxtoby M. J., Caldwell M. B., Gwinn M. L., Rogers M. F. Pneumocystis carinii pneumonia among US children with perinatally acquired HIV infection. JAMA. 1993 Jul 28;270(4):470–473. [PubMed] [Google Scholar]
  177. Simpson B. J., Andiman W. A. Difficulties in assigning human immunodeficiency virus-1 infection and seroreversion status in a cohort of HIV-exposed in children using serologic criteria established by the Centers for Disease Control and Prevention. Pediatrics. 1994 May;93(5):840–842. [PubMed] [Google Scholar]
  178. Sinnott J. T., 4th, Cullison J. P., Sweeney M. S., Hammond M., Holt D. A. Respiratory syncytial virus pneumonia in a cardiac transplant recipient. J Infect Dis. 1988 Sep;158(3):650–651. doi: 10.1093/infdis/158.3.650. [DOI] [PubMed] [Google Scholar]
  179. Soave R. Cryptosporidiosis and isosporiasis in patients with AIDS. Infect Dis Clin North Am. 1988 Jun;2(2):485–493. [PubMed] [Google Scholar]
  180. Solal-Celigny P., Couderc L. J., Herman D., Herve P., Schaffar-Deshayes L., Brun-Vezinet F., Tricot G., Clauvel J. P. Lymphoid interstitial pneumonitis in acquired immunodeficiency syndrome-related complex. Am Rev Respir Dis. 1985 Jun;131(6):956–960. doi: 10.1164/arrd.1985.131.6.956. [DOI] [PubMed] [Google Scholar]
  181. Spector S. A., Gelber R. D., McGrath N., Wara D., Barzilai A., Abrams E., Bryson Y. J., Dankner W. M., Livingston R. A., Connor E. M. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. N Engl J Med. 1994 Nov 3;331(18):1181–1187. doi: 10.1056/NEJM199411033311802. [DOI] [PubMed] [Google Scholar]
  182. Sperber S. J., Schleupner C. J. Salmonellosis during infection with human immunodeficiency virus. Rev Infect Dis. 1987 Sep-Oct;9(5):925–934. doi: 10.1093/clinids/9.5.925. [DOI] [PubMed] [Google Scholar]
  183. Steckelberg J. M., Cockerill F. R., 3rd Serologic testing for human immunodeficiency virus antibodies. Mayo Clin Proc. 1988 Apr;63(4):373–380. doi: 10.1016/s0025-6196(12)64860-5. [DOI] [PubMed] [Google Scholar]
  184. Stein D. S., Timpone J. G., Gradon J. D., Kagan J. M., Schnittman S. M. Immune-based therapeutics: scientific rationale and the promising approaches to the treatment of the human immunodeficiency virus-infected individual. Clin Infect Dis. 1993 Oct;17(4):749–771. doi: 10.1093/clinids/17.4.749. [DOI] [PubMed] [Google Scholar]
  185. Stewart J. A., Reef S. E., Pellett P. E., Corey L., Whitley R. J. Herpesvirus infections in persons infected with human immunodeficiency virus. Clin Infect Dis. 1995 Aug;21 (Suppl 1):S114–S120. doi: 10.1093/clinids/21.supplement_1.s114. [DOI] [PubMed] [Google Scholar]
  186. Stiehm E. R., Vink P. Transmission of human immunodeficiency virus infection by breast-feeding. J Pediatr. 1991 Mar;118(3):410–412. doi: 10.1016/s0022-3476(05)82157-2. [DOI] [PubMed] [Google Scholar]
  187. Straka B. F., Whitaker D. L., Morrison S. H., Oleske J. M., Grant-Kels J. M. Cutaneous manifestations of the acquired immunodeficiency syndrome in children. J Am Acad Dermatol. 1988 May;18(5 Pt 1):1089–1102. doi: 10.1016/s0190-9622(88)70112-7. [DOI] [PubMed] [Google Scholar]
  188. Strauss J., Abitbol C., Zilleruelo G., Scott G., Paredes A., Malaga S., Montané B., Mitchell C., Parks W., Pardo V. Renal disease in children with the acquired immunodeficiency syndrome. N Engl J Med. 1989 Sep 7;321(10):625–630. doi: 10.1056/NEJM198909073211001. [DOI] [PubMed] [Google Scholar]
  189. Tappero J. W., Perkins B. A., Wenger J. D., Berger T. G. Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus. Clin Microbiol Rev. 1995 Jul;8(3):440–450. doi: 10.1128/cmr.8.3.440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Tovo P. A., de Martino M., Gabiano C., Cappello N., D'Elia R., Loy A., Plebani A., Zuccotti G. V., Dallacasa P., Ferraris G. Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children. Lancet. 1992 May 23;339(8804):1249–1253. doi: 10.1016/0140-6736(92)91592-v. [DOI] [PubMed] [Google Scholar]
  191. Trang J. M., Kidd L., Gruber W., Storch G., Demmler G., Jacobs R., Dankner W., Starr S., Pass R., Stagno S. Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group. Clin Pharmacol Ther. 1993 Jan;53(1):15–21. doi: 10.1038/clpt.1993.4. [DOI] [PubMed] [Google Scholar]
  192. Tudor-Williams G. Early diagnosis of vertically acquired HIV-1 infection. AIDS. 1991 Jan;5(1):103–105. doi: 10.1097/00002030-199101000-00017. [DOI] [PubMed] [Google Scholar]
  193. Ukwu H. N., Graham B. S., Lambert J. S., Wright P. F. Perinatal transmission of human immunodeficiency virus-1 infection and maternal immunization strategies for prevention. Obstet Gynecol. 1992 Sep;80(3 Pt 1):458–468. [PubMed] [Google Scholar]
  194. Ultmann M. H., Belman A. L., Ruff H. A., Novick B. E., Cone-Wesson B., Cohen H. J., Rubinstein A. Developmental abnormalities in infants and children with acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Dev Med Child Neurol. 1985 Oct;27(5):563–571. doi: 10.1111/j.1469-8749.1985.tb14127.x. [DOI] [PubMed] [Google Scholar]
  195. Ultmann M. H., Diamond G. W., Ruff H. A., Belman A. L., Novick B. E., Rubinstein A., Cohen H. J. Developmental abnormalities in children with acquired immunodeficiency syndrome (AIDS): a follow-up study. Int J Neurosci. 1987 Feb;32(3-4):661–667. doi: 10.3109/00207458709043320. [DOI] [PubMed] [Google Scholar]
  196. Vaira D., Miglioli M., Menegatti M., Holton J., Boschini A., Vergura M., Ricci C., Azzarone P., Mulè P., Barbara L. Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients. Dig Dis Sci. 1995 Aug;40(8):1622–1626. doi: 10.1007/BF02212680. [DOI] [PubMed] [Google Scholar]
  197. Van de Perre P., Simonon A., Hitimana D. G., Dabis F., Msellati P., Mukamabano B., Butera J. B., Van Goethem C., Karita E., Lepage P. Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet. 1993 Apr 10;341(8850):914–918. doi: 10.1016/0140-6736(93)91210-d. [DOI] [PubMed] [Google Scholar]
  198. Wahn V., Kramer H. H., Voit T., Brüster H. T., Scrampical B., Scheid A. Horizontal transmission of HIV infection between two siblings. Lancet. 1986 Sep 20;2(8508):694–694. doi: 10.1016/s0140-6736(86)90209-6. [DOI] [PubMed] [Google Scholar]
  199. Weiblen B. J., Lee F. K., Cooper E. R., Landesman S. H., McIntosh K., Harris J. A., Nesheim S., Mendez H., Pelton S. I., Nahmias A. J. Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies. Lancet. 1990 Apr 28;335(8696):988–990. doi: 10.1016/0140-6736(90)91061-e. [DOI] [PubMed] [Google Scholar]
  200. Wentworth B. B., Alexander E. R. Seroepidemiology of infectious due to members of the herpesvirus group. Am J Epidemiol. 1971 Nov;94(5):496–507. doi: 10.1093/oxfordjournals.aje.a121347. [DOI] [PubMed] [Google Scholar]
  201. White D. A., Matthay R. A. Noninfectious pulmonary complications of infection with the human immunodeficiency virus. Am Rev Respir Dis. 1989 Dec;140(6):1763–1787. doi: 10.1164/ajrccm/140.6.1763. [DOI] [PubMed] [Google Scholar]
  202. Wilfert C. M. Mandatory screening of pregnant women for the human immunodeficiency virus. Clin Infect Dis. 1994 Oct;19(4):664–666. doi: 10.1093/clinids/19.4.664. [DOI] [PubMed] [Google Scholar]
  203. Wong B., Edwards F. F., Kiehn T. E., Whimbey E., Donnelly H., Bernard E. M., Gold J. W., Armstrong D. Continuous high-grade mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome. Am J Med. 1985 Jan;78(1):35–40. doi: 10.1016/0002-9343(85)90458-9. [DOI] [PubMed] [Google Scholar]
  204. Wrzolek M. A., Brudkowska J., Kozlowski P. B., Rao C., Anzil A. P., Klein E. A., Del Rosario C., Abdu A., Kaufman L., Chandler F. W. Opportunistic infections of the central nervous system in children with HIV infection: report of 9 autopsy cases and review of literature. Clin Neuropathol. 1995 Jul-Aug;14(4):187–196. [PubMed] [Google Scholar]
  205. Yolken R. H., Hart W., Oung I., Shiff C., Greenson J., Perman J. A. Gastrointestinal dysfunction and disaccharide intolerance in children infected with human immunodeficiency virus. J Pediatr. 1991 Mar;118(3):359–363. doi: 10.1016/s0022-3476(05)82147-x. [DOI] [PubMed] [Google Scholar]
  206. Zaia J. A., Levin M. J., Preblud S. R., Leszczynski J., Wright G. G., Ellis R. J., Curtis A. C., Valerio M. A., LeGore J. Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J Infect Dis. 1983 Apr;147(4):737–743. doi: 10.1093/infdis/147.4.737. [DOI] [PubMed] [Google Scholar]
  207. Ziegler J. L., Katongole-Mbidde E. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer. 1996 Jan 17;65(2):200–203. doi: 10.1002/(SICI)1097-0215(19960117)65:2<200::AID-IJC12>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  208. Zolla-Pazner S., Gorny M. K. Passive immunization for the prevention and treatment of HIV infection. AIDS. 1992 Nov;6(11):1235–1247. doi: 10.1097/00002030-199211000-00001. [DOI] [PubMed] [Google Scholar]
  209. de Blic J., Blanche S., Danel C., Le Bourgeois M., Caniglia M., Scheinmann P. Bronchoalveolar lavage in HIV infected patients with interstitial pneumonitis. Arch Dis Child. 1989 Sep;64(9):1246–1250. doi: 10.1136/adc.64.9.1246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  210. de Martino M., Tovo P. A., Galli L., Gabiano C., Cozzani S., Gotta C., Scarlatti G., Fiocchi A., Cocchi P., Marchisio P. Prognostic significance of immunologic changes in 675 infants perinatally exposed to human immunodeficiency virus. The Italian Register for Human Immunodeficiency Virus Infection in Children. J Pediatr. 1991 Nov;119(5):702–709. doi: 10.1016/s0022-3476(05)80283-5. [DOI] [PubMed] [Google Scholar]
  211. de Martino M., Tovo P. A., Tozzi A. E., Pezzotti P., Galli L., Livadiotti S., Caselli D., Massironi E., Ruga E., Fioredda F. HIV-1 transmission through breast-milk: appraisal of risk according to duration of feeding. AIDS. 1992 Sep;6(9):991–997. [PubMed] [Google Scholar]
  212. von Roenn J. H., Murphy R. L., Weber K. M., Williams L. M., Weitzman S. A. Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection. Ann Intern Med. 1988 Nov 15;109(10):840–841. doi: 10.7326/0003-4819-109-10-840. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES